These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 27414737)

  • 41. Tailored echocardiographic interventricular delay programming further optimizes left ventricular performance after cardiac resynchronization therapy.
    Vanderheyden M; De Backer T; Rivero-Ayerza M; Geelen P; Bartunek J; Verstreken S; De Zutter M; Goethals M
    Heart Rhythm; 2005 Oct; 2(10):1066-72. PubMed ID: 16188583
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A randomized study of haemodynamic effects and left ventricular dyssynchrony in right ventricular apical vs. high posterior septal pacing in cardiac resynchronization therapy.
    Kristiansen HM; Vollan G; Hovstad T; Keilegavlen H; Faerestrand S
    Eur J Heart Fail; 2012 May; 14(5):506-16. PubMed ID: 22286156
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The right ventricular septum presents the optimum site for maximal electrical separation during left ventricular pacing.
    Miranda RI; Nault M; Simpson CS; Michael KA; Abdollah H; Baranchuk A; Redfearn DP
    J Cardiovasc Electrophysiol; 2012 Apr; 23(4):370-4. PubMed ID: 22049976
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Long-term impact of cardiac resynchronization therapy in mild heart failure: 5-year results from the REsynchronization reVErses Remodeling in Systolic left vEntricular dysfunction (REVERSE) study.
    Linde C; Gold MR; Abraham WT; St John Sutton M; Ghio S; Cerkvenik J; Daubert C;
    Eur Heart J; 2013 Sep; 34(33):2592-9. PubMed ID: 23641006
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effect of left ventricular endocardial activation pattern on echocardiographic and clinical response to cardiac resynchronization therapy.
    Fung JW; Chan JY; Yip GW; Chan HC; Chan WW; Zhang Q; Yu CM
    Heart; 2007 Apr; 93(4):432-7. PubMed ID: 17237127
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Primary results from the SmartDelay determined AV optimization: a comparison to other AV delay methods used in cardiac resynchronization therapy (SMART-AV) trial: a randomized trial comparing empirical, echocardiography-guided, and algorithmic atrioventricular delay programming in cardiac resynchronization therapy.
    Ellenbogen KA; Gold MR; Meyer TE; Fernndez Lozano I; Mittal S; Waggoner AD; Lemke B; Singh JP; Spinale FG; Van Eyk JE; Whitehill J; Weiner S; Bedi M; Rapkin J; Stein KM
    Circulation; 2010 Dec; 122(25):2660-8. PubMed ID: 21098426
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cardiac resynchronization therapy: Twelve-month effects of echocardiographic atrio-ventricular and inter-ventricular delay optimization. Rationale and design of the CARTEDO trial.
    Donazzan L; Rigolli M; De Simone V; Bergamini C; Tomasi L; Zanolla L; Vassanelli C
    Int J Cardiol; 2016 Jan; 202():185-7. PubMed ID: 26397407
    [No Abstract]   [Full Text] [Related]  

  • 48. Concepts and questions in programming cardiac resynchronization devices.
    Scharf C; Attenhofer Jost CH
    Heart Rhythm; 2005 Oct; 2(10):1073-5. PubMed ID: 16188584
    [No Abstract]   [Full Text] [Related]  

  • 49. Three-dimensional propagation imaging of left ventricular activation by speckle-tracking echocardiography to predict responses to cardiac resynchronization therapy.
    Seo Y; Ishizu T; Kawamura R; Yamamoto M; Kuroki K; Igarashi M; Sekiguchi Y; Nogami A; Aonuma K
    J Am Soc Echocardiogr; 2015 May; 28(5):606-14. PubMed ID: 25797706
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Determination of the longest intrapatient left ventricular electrical delay may predict acute hemodynamic improvement in patients after cardiac resynchronization therapy.
    Zanon F; Baracca E; Pastore G; Fraccaro C; Roncon L; Aggio S; Noventa F; Mazza A; Prinzen F
    Circ Arrhythm Electrophysiol; 2014 Jun; 7(3):377-83. PubMed ID: 24668162
    [TBL] [Abstract][Full Text] [Related]  

  • 51. New evidence for favourable effects on haemodynamics and ventricular performance after Parachute(®) implantation in humans.
    Schmidt T; Frerker C; Thielsen T; Dotz I; Wohlmuth P; Kuck KH; Schäfer U
    Eur J Heart Fail; 2014 Oct; 16(10):1112-9. PubMed ID: 25298333
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cardiac resynchronization therapy: what? Who? When? How?
    Cuculich PS; Joseph S
    Am J Med; 2011 Sep; 124(9):813-5. PubMed ID: 21854888
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The impact of a strategy of image-guided left ventricular lead placement during cardiac resynchronization therapy on health care utilization.
    Rodriguez Y; Nan J; Yasin O; Gorcsan J; Saba S
    Int J Cardiol; 2015; 187():311-2. PubMed ID: 25839631
    [No Abstract]   [Full Text] [Related]  

  • 54. Analysis of left ventricular function in patients with heart failure undergoing cardiac resynchronization.
    Benfatti RA; Manzano FM; Pontes JC; Dias AE; Duarte JJ; Silva GV; Gomes Junior JF; Gardenal N
    Rev Bras Cir Cardiovasc; 2013 Mar; 28(1):69-75. PubMed ID: 23739935
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Clinical factors and echocardiographic techniques related to the presence, size, and location of acoustic windows for leadless cardiac pacing.
    DeFaria Yeh D; Lonergan KL; Fu D; Yeh RW; Echt DS; Foster E
    Europace; 2011 Dec; 13(12):1760-5. PubMed ID: 21798878
    [TBL] [Abstract][Full Text] [Related]  

  • 56. New insights into ventricular interactions during cardiac resynchronization.
    Daubert C; Behaghel A; Martins RP
    J Am Coll Cardiol; 2013 Dec; 62(25):2404-2405. PubMed ID: 24013053
    [No Abstract]   [Full Text] [Related]  

  • 57. Prognostic benefit of optimum left ventricular lead position in cardiac resynchronization therapy: follow-up of the TARGET Study Cohort (Targeted Left Ventricular Lead Placement to guide Cardiac Resynchronization Therapy).
    Kydd AC; Khan FZ; Watson WD; Pugh PJ; Virdee MS; Dutka DP
    JACC Heart Fail; 2014 Jun; 2(3):205-12. PubMed ID: 24952685
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cardiac resynchronization therapy in heart failure patients with less severe left ventricular dysfunction.
    Hai OY; Mentz RJ; Zannad F; Gasparini M; De Ferrari GM; Daubert JC; Holzmeister J; Lam CS; Pochet T; Vincent A; Linde C
    Eur J Heart Fail; 2015 Feb; 17(2):135-43. PubMed ID: 25469668
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Right ventricular septal pacing as alternative for failed left ventricular lead implantation in cardiac resynchronization therapy candidates.
    Alhous MH; Small GR; Hannah A; Hillis GS; Frenneaux M; Broadhurst PA
    Europace; 2015 Jan; 17(1):94-100. PubMed ID: 25359384
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cardiac Resynchronization Therapy: Potential of Left Ventricular Pacing.
    Matusik PT
    Eur Heart J; 2019 Jun; 40(21):1667-1669. PubMed ID: 31152550
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.